Glioblastoma stem cells resistant to temozolomide-induced autophagy
Glioblastoma stem cells resistant to temozolomide-induced autophagy
复制标题
胶质母细胞瘤干细胞对替莫唑胺诱导的自噬具有抵抗力
DOI:
10.3760/cma.j.issn.0366-6999.2009.11.004
复制
发表时间:
2009-06-05
影响因子:
6.1
通讯作者:
Chen Zhong-ping
中科院分区:
文献类型:
--
作者:
Fu Jun;Liu Zhi-gang;Chen Zhong-ping
Background Recent studies have demonstrated the existence of a small fraction of cells with features of primitive neural progenitor cells and tumor-initiating function in brain tumors. These cells might represent primary therapeutic target for complete eradication of the tumors. This study aimed to determine the resistant phenotype of glioblastoma stem cells (GSCs) to temozolomide (TMZ) and to explore the possible molecular mechanisms underlying TMZ resistance.Methods Freshly resected glioblastoma specimen was collected and magnetic isolation of GSCs was carried out using the Miltenyi Biotec CD133 Cell Isolation kit. The cytotoxic effect of TMZ on CD133(+) and CD133(-) glioblastoma cells was determined by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Autophagy-related proteins (Beclin-1, LC3 and Atg5) and cleaved caspase-3 (p17) were analyzed by Western blotting. Immunofluorescent staining was used to detect Atg5, glial fibrillary acidic protein (GFAP) and CD133 expression in glioblastoma cells. Statistical analysis was carried out using SPSS 10.0 software. For all tests, the level of statistical significance was set at P